Business Wire

Dr. Reddy's Laboratories Announces the Launch of Testosterone Gel, 1.62% (20.25 mg/1.25 g Pump Actuation) in the U.S. Market

HYDERABAD, India & PRINCETON, N.J.--(BUSINESS WIRE)--Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today ...
FierceBiotech

Endo Pharmaceuticals Receives FDA Approval for FORTESTA(TM) (Testosterone) Gel as a Class III Product for Topical Use for Men wi

Endo Pharmaceuticals Receives FDA Approval for FORTESTA(TM) (Testosterone) Gel as a Class III Product for Topical Use for Men with Low Testosterone FORTESTA Gel is the first approved testosterone ...
Pharmabiz

Endo Pharma launches Fortesta gel in US to treat low testosterone in adult males

Endo Pharmaceuticals announced that Fortesta Gel - recently approved by the US Food and Drug Administration for the treatment of low testosterone, or ‘Low T’ in adult males - is now available by ...